Literature DB >> 22373485

Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs.

Janine Biermann, Till Neumann, Christiane E Angermann, Raimund Erbel, Bernhard Maisch, David Pittrow, Vera Regitz-Zagrosek, Thomas Scheffold, Rolf Wachter, Götz Gelbrich, Jürgen Wasem, Anja Neumann.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22373485     DOI： 10.1016/j.ijcard.2012.01.099

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  8 in total

1.  Cardiac Depression Scale: Mokken scaling in heart failure patients.

Authors:  Chantal F Ski; David R Thompson; David L Hare; Andrew G Stewart; Roger Watson
Journal:  Health Qual Life Outcomes       Date:  2012-11-23       Impact factor: 3.186

2.  Costs of treating cardiovascular events in Germany: a systematic literature review.

Authors:  Tamara Schmid
Journal:  Health Econ Rev       Date:  2015-09-23

3.  Exploratory cost-effectiveness analysis of cardiac resynchronization therapy with systematic device optimization vs. standard (non-systematic) optimization: a multinational economic evaluation.

Authors:  Kurt Banz; Peter Paul Delnoy; Jean Renaud Billuart
Journal:  Health Econ Rev       Date:  2015-07-11

4.  Differences in the predictive value of red cell distribution width for the mortality of patients with heart failure due to various heart diseases.

Authors:  Yang Zhang; Yan Wang; Jin-Suo Kang; Jin-Xing Yu; Shi-Jie Yin; Xiang-Feng Cong; Xi Chen
Journal:  J Geriatr Cardiol       Date:  2015-11       Impact factor: 3.327

5.  Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany.

Authors:  Ulrike Theidel; Saku Väätäinen; Janne Martikainen; Erkki Soini; Thomas Hardt; Wolfram Doehner
Journal:  ESC Heart Fail       Date:  2017-07-03

6.  Economic impact of heart failure with preserved ejection fraction: insights from the ALDO-DHF trial.

Authors:  Djawid Hashemi; Ludwig Dettmann; Tobias D Trippel; Volker Holzendorf; Johannes Petutschnigg; Rolf Wachter; Gerd Hasenfuß; Burkert Pieske; Antonia Zapf; Frank Edelmann
Journal:  ESC Heart Fail       Date:  2020-01-27

7.  Risk of end-stage renal disease in patients with hypertrophic cardiomyopathy: A nationwide population-based cohort study.

Authors:  Heesun Lee; Kyungdo Han; Jun-Bean Park; In-Chang Hwang; Yeonyee E Yoon; Hyo Eun Park; Su-Yeon Choi; Yong-Jin Kim; Goo-Yeong Cho; Hyung-Kwan Kim; Steve R Ommen
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

8.  A novel hybrid modeling approach for the evaluation of integrated care and economic outcome in heart failure treatment.

Authors:  Alexander Lassnig; Theresa Rienmueller; Diether Kramer; Werner Leodolter; Christian Baumgartner; Joerg Schroettner
Journal:  BMC Med Inform Decis Mak       Date:  2019-11-21       Impact factor: 2.796
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.